$VKTX ๐ก
Bill Reisner new VP of Market Access at Viking Therapeutics.
He led the U.S. market access strategy for the launch of Eli Lilly's tirzepatide.
| Truist Securities ๐บ๐ฎ๐ถ๐ป๐๐ฎ๐ถ๐ป๐ ๐๐๐ on ๐ฉ๐ถ๐ธ๐ถ๐ป๐ด ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ฒ๐๐๐ถ๐ฐ๐ with 85$ PT